Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NP-031112 and NP-00111 demonstrate neuroprotectant effects

Oct. 1, 2004

Uriach selects UR-14048 for further development for parenteral treatment of acute pain

Oct. 1, 2004

New phase II study for M-40403 in cancer pain

Oct. 1, 2004

New vanilloid VR1 antagonists and their use in pain, urinary incontinence, etc.

Oct. 1, 2004

mGlu4 receptor modulator has anxiolytic-like effects

Sep. 30, 2004

Schwarz launches Parcopa

Sep. 30, 2004

Palladone extended-release capsules approved for persistent pain

Sep. 30, 2004

Ono presents new prostanoid EP3 antagonists and their use in pain and other disorders

Sep. 30, 2004

Novel muscarinic M4 agonists with potential in schizophrenia therapy

Sep. 30, 2004

Reduced GI tract mucosal injury seen with AZD-3582

Sep. 29, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026